Deirdre P. Connelly
President, Eli Lilly and Company.
Companies
- Sarepta TherapeuticsBoard member Sep 16, 2024 to now1
- Lincoln National CorporationBoard member Jun 6, 2016 to now2
- Macy's, Inc.Board member Jan 4, 2008 to now3
- Eli Lilly and CompanyPresident Aug 19, 2005 to Jan 29, 20094
- Eli Lilly and CompanySenior VP, Human Resources Oct 8, 2004 to Mar 24, 20055
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY55,829 shares6$70.2M at $1,257.32Feb 5, 2008
Sarepta Therapeutics SRPT22,100 shares7$391.5K at $17.71Jun 4, 2026
Lincoln National Corporation LNC4,000 shares8$159.2K at $39.80Nov 18, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Granted 16,875 shares of Sarepta Therapeutics7
- Mar 10, 2025Granted 2,383 shares of Sarepta Therapeutics9
- Sep 12, 2024Granted 2,842 shares of Sarepta Therapeutics10
- Nov 18, 2022Bought 3,000 shares at $37.41 of Lincoln National Corporation8
- May 4, 2018Bought 1,000 shares at $67.09 of Lincoln National Corporation11
- Feb 1, 2008Shares withheld for tax 6,432 shares at $51.52 of Eli Lilly and Company6
- Jan 25, 2008Granted 26,276 shares at $50.74 of Eli Lilly and Company12
- Feb 1, 2007Shares withheld for tax 3,925 shares at $54.12 of Eli Lilly and Company13
- Jan 17, 2007Granted 20,025 shares at $52.86 of Eli Lilly and Company14
- Dec 14, 2006Sold 2,141 shares at $54.12 of Eli Lilly and Company15
- Aug 8, 2006Shares withheld for tax 2,080 shares at $55.13 of Eli Lilly and Company16
- Aug 8, 2006Exercised options 2,800 shares at $34.59 of Eli Lilly and Company16
- Jan 20, 2006Granted 12,579 shares at $57.04 of Eli Lilly and Company17
- Aug 17, 2005Shares withheld for tax 1,243 shares at $52.73 of Eli Lilly and Company18
- Aug 17, 2005Shares withheld for tax 1,721 shares at $52.90 of Eli Lilly and Company18
- Aug 17, 2005Exercised options 2,800 shares at $23.41 of Eli Lilly and Company18
- Aug 17, 2005Exercised options 2,800 shares at $23.41 of Eli Lilly and Company18
- Jan 14, 2005Granted 569 shares at $56.79 of Eli Lilly and Company19
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Nov 18, 2022 | LNC | Buy | $112.2K | +6.0% | −88.8% | −52.0% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSarepta Therapeutics, Board member
- 2
- 3SEC EDGARMacy's, Inc., Board member
- 4SEC EDGAREli Lilly and Company, President
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Mar 11, 2025
- 10SEC EDGARForm 4 filed Sep 16, 2024
- 11SEC EDGARForm 4 filed May 22, 2018
- 12SEC EDGARForm 4 filed Jan 29, 2008
- 13SEC EDGARForm 4 filed Feb 5, 2007
- 14SEC EDGARForm 4 filed Jan 19, 2007
- 15SEC EDGARForm 4 filed Dec 18, 2006
- 16SEC EDGARForm 4 filed Aug 9, 2006
- 17SEC EDGARForm 4 filed Jan 24, 2006
- 18SEC EDGARForm 4 filed Aug 19, 2005
- 19SEC EDGARForm 4 filed Jan 18, 2005